| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703467 | Null | 0.0181211508101519 | 0.35652184 |
| NSC 711745 | Null | 0.0181211508101519 | 0.20799137 |
| NSC 718728 | 5-[2-(2,5-Dimethoxyphenyl)ethynyl]-2-methoxyphenyl-N- [2-(4-fluorophenyl)ethyl]carboxamide | 0.0181211508101519 | 0.24186765 |
| NSC 726262 | 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one | 0.0181211508101519 | 0.2586342 |
| NSC 731201 | ethyl 6,7-dichloro-3-phenyl-2-quinoxalincarboxylate 1,4-dioxide | 0.0181211508101519 | 0.054445202 |
| NSC 736164 | pyrazoline derivative | 0.0181211508101519 | 0.12627546 |
| NSC 744025 | diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate | 0.0181211508101519 | 0.16527112 |
| NSC 749379 | Null | 0.0181211508101519 | 0.36192408 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0181211508101519 | 0.28883134 |
| NSC 88054 | Null | 0.0181211508101519 | 0.20555506 |